secwatch / observer
8-K filed October 16, 2023, 7:59 PM ET ticker BGLC CIK 0001737523
leadership confidence high sentiment neutral materiality 0.60

Bionexus Gene Lab appoints Chi Yuen Leong as CEO and director, effective Oct 12, 2023

BioNexus Gene Lab Corp

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Chi Yuen Leong

Chief Executive Officer
BGLC · BioNexus Gene Lab Corp
Effective
2023-10-12
Filed
October 16, 2023, 7:59 PM ET
On October 12, 2023, the board of directors of the Bionexus Gene Lab Corp. (“the Company”) approved the appointment of Mr. Chi Yuen Leong as the Chief Executive Officer and a director, effective October 12, 2023.
Appointed

Chi Yuen Leong

Director
BGLC · BioNexus Gene Lab Corp
Effective
2023-10-12
Filed
October 16, 2023, 7:59 PM ET
On October 12, 2023, the board of directors of the Bionexus Gene Lab Corp. (“the Company”) approved the appointment of Mr. Chi Yuen Leong as the Chief Executive Officer and a director, effective October 12, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Chi Yuen Leong was appointed as Chief Executive Officer at BioNexus Gene Lab Corp.

Action
appointed
Role
Chief Executive Officer
Exact text from the filing
On October 12, 2023, the board of directors of the Bionexus Gene Lab Corp. (“the Company”) approved the appointment of Mr. Chi Yuen Leong as the Chief Executive Officer and a director, effective October 12, 2023.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Chi Yuen Leong was appointed as Director at BioNexus Gene Lab Corp.

Action
appointed
Role
Director
Exact text from the filing
On October 12, 2023, the board of directors of the Bionexus Gene Lab Corp. (“the Company”) approved the appointment of Mr. Chi Yuen Leong as the Chief Executive Officer and a director, effective October 12, 2023.
View on SEC.gov

BioNexus Gene Lab Corp filing history →

Source: SEC EDGAR
accession 0001477932-23-007651
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.